Alpha Tau Medical Ltd
NASDAQ: DRTS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Uzi Sofer
- Employees
- 118
- Headquarters
- Jerusalem, Israel
- IPO year
- 2021
- Market cap
- $907.8M
- Website
- https://www.alphatau.com
Loading DRTS…
Loading profile data…Frequently asked questions about DRTS
What does Alpha Tau Medical Ltd (DRTS) do?
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, live...
Where does DRTS trade?
Alpha Tau Medical Ltd (DRTS) trades on the NASDAQ.
What sector is DRTS in?
Alpha Tau Medical Ltd (DRTS) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Alpha Tau Medical Ltd?
Uzi Sofer is the chief executive officer of Alpha Tau Medical Ltd (DRTS).
Where is Alpha Tau Medical Ltd headquartered?
Alpha Tau Medical Ltd is headquartered in Israel.
Does DRTS pay a dividend?
Alpha Tau Medical Ltd (DRTS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DRTS go public?
Alpha Tau Medical Ltd (DRTS) completed its initial public offering in 2021.